Best of Hematology and Breast Cancer™ 2026, Baton Rouge

Accreditation: 6.75 AMA PRA Category 1 Credit™ | 6.75 ABIM MOC II | 6.75 ACPE Pharmacy | 6.75 Nursing Contact Hours

Venue: Embassy Suites by Hilton Baton Rouge, 4914 Constitution Avenue, Baton Rouge, LA, United States

Start Date: February 28, 2026

Faculty disclosures

Identification and mitigation of potential conflicts of interest

All conflict of interest has been identified and mitigated for individuals in control of contents.

Planning committee disclosure statement

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

Conference Chairs

Shashank Cingam, MD has a financial relationship (Advisor) with Janssen Pharamceuticals; financial relationship (Advisor) with Janssen Pharamceuticals; financial relationship (Grant Or Contract) with Pfizer.

Sindhu Priya Devarashetty, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.

Session Chairs

Praveen Ramakrishnan Geethakumari, MD, MBA has a financial relationship (Advisor) with BMS; financial relationship (Advisor) with ADC Therapeutics; financial relationship (Advisor) with Kite/ Gilead; financial relationship (Advisor) with Acrotech Biopharma; financial relationship (Advisor) with ONO Pharma; financial relationship (Advisor) with IPSEN Pharma; financial relationship (Advisor) with Regeneron; financial relationship (Advisor) with Sobi.

Laura Finn, MD has a financial relationship (Speaker) with BeOne.

Neelima Chintapalli, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.

Girindra Raval, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.

Ankita Gupta, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.

Poornima Ramadas, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.

Shiva Jashwanth Gaddam, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.

Faculty

Clark Alsfeld, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.

Mindy Bowie, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.

Suvarna Guvvala, MD, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.

Kyle Jakob, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.

Kimberly LeBlanc, MD No, I have not had a financial relationship with an ineligible company within the past 24 months.

Radhika Gangaraju, MD has a financial relationship (Professional Service) with ABIM Item Writing Task Force, HTRS Chair of the Research Colloquium, ISTH Training Committee member; financial relationship (Researcher) with Received research funding from Sanofi, Ricordati; financial relationship (Grant Or Contract) with Research funding from NIH, American Society of Hematology; financial relationship (Ownership Interest) with Rex Services LLC; financial relationship (Consultant) with Sanofi, Novartis, 2nd MD; financial relationship (Contractor) with US Thrombotic Microangiopathy Consortium, Venous thromboEmbolism Network U.S. (VENUS); financial relationship (Employee) with University of Alabama at Birmingham.

Vishwas Sakhalkar, MD has a financial relationship (Ownership Interest) with Gilead sciences, Doximity; financial relationship (Grant Or Contract) with Pfizer.

Tatiana Han, DO No, I have not had a financial relationship with an ineligible company within the past 24 months.

Mark Henry Dalgetty, DO No, I have not had a financial relationship with an ineligible company within the past 24 months.

Maissaa Janbain, MD has a financial relationship (Consultant) with Sanofi, Takeda, CSL Behring, Genentech, Hema Biologics, Pfizer; financial relationship (Speaker) with Sanofi/sobi , Takeda, CSL Behring, Hema Biologics, Pfizer; financial relationship (Employee) with Tulane School of Medicine; financial relationship (Grant Or Contract) with genentech; financial relationship (Researcher) with institutional support for being Site PI with Hemab, Genentech and Regeneron.

Michelle Loch, MD has a financial relationship (Professional Services) with Gilead; financial relationship (Professional Services) with Astra Zeneca.

Staff

Matt Lambert, n/a has a financial relationship (Employee) with Binaytara.

Binay Shah, MD, MHA No, I have not had a financial relationship with an ineligible company within the past 24 months.

Anna Kharzhevskaia, PhD No, I have not had a financial relationship with an ineligible company within the past 24 months.